How Many Under-Eye Peptide Treatments Are Needed to See Results?

Marta Morozova
September 1, 2026

Registered Nurse. Nurse-led aesthetics practice in Vaughan, serving Toronto and the GTA.

Introduction

The under-eye area is one of the first places where changes in skin quality, hydration, volume, and facial structure can become noticeable. Because the skin around the eyes is thin and delicate, concerns such as crepiness, fine lines, hollowness, shadows, and a tired appearance can be particularly visible.

For patients considering peptide-based rejuvenation, one of the most practical questions is: how many under-eye peptide treatments are needed before a noticeable improvement can be expected?

There is no universal number that applies to every patient. Treatment frequency depends on the specific product and protocol being used, the condition of the under-eye tissue, the concern being addressed, individual response, and whether another anatomical issue—such as midface volume loss—is contributing to the appearance.

This distinction is important because under-eye rejuvenation is not simply about treating whatever looks dark or hollow. A thorough assessment should determine whether the concern originates primarily from skin quality, volume loss, pigmentation, vascular visibility, facial anatomy, or a combination of factors.

At Aesthetic Nurse Marta, the Under-Eye Peptide Rejuvenation approach emphasizes evaluating the surrounding facial structure and tissue quality before deciding on treatment. That individualized assessment is ultimately more useful than choosing an arbitrary number of sessions in advance.

TLDR Quick Guide

How Many Under-Eye Peptide Treatments Are Needed?

There isn’t one treatment number that guarantees the same result for everyone.

Depending on the treatment protocol and individual assessment, under-eye peptide rejuvenation may be approached as a series of sessions rather than a one-time treatment. The exact number, spacing, and need for maintenance should be determined by the treating provider based on the product used and how the area responds.

Several factors can influence the treatment plan:

Current under-eye skin quality
Degree of crepiness or fine lines
Hydration and tissue condition
Age-related changes
Individual response to treatment
The specific injectable or mesotherapy formulation
Whether hollowness is contributing to shadowing
Midface and cheek support
Previous under-eye treatments
Overall facial anatomy
Treatment goals
Whether combination treatment is appropriate

Some patients may begin noticing changes during a treatment series, while others may require more time before improvement becomes apparent. Peptide-based approaches should not be confused with treatments intended to create immediate structural volume, so realistic expectations are essential.

Why Treatment Numbers Vary From Person to Person

Under-Eye Concerns Can Have Different Causes

Two patients can both describe their concern as “tired-looking eyes” while having completely different anatomical reasons for that appearance.

One person may primarily have thin or crepey skin.

Another may have a pronounced tear-trough shadow related to facial structure.

Someone else may have pigmentation, visible vessels, puffiness, midface volume changes, or several concerns simultaneously.

That means treatment cannot be selected solely from the symptom description.

Before deciding how many sessions might be appropriate, the provider first needs to determine what is actually being treated.

Treatment Goals Also Matter

The patient’s desired outcome affects the plan.

Someone seeking subtle improvement in skin quality may have a different treatment strategy from someone concerned about substantial hollowness or structural changes.

Peptide rejuvenation also shouldn’t be expected to accomplish everything that fillers, collagen-stimulating treatments, PRP/PRF, resurfacing procedures, or surgery can potentially address.

Choosing the right treatment category comes before choosing the number of treatments.

What Under-Eye Peptide Rejuvenation Is Designed to Address

The Focus Is Tissue Quality Rather Than Simply Adding Volume

Peptide-based under-eye treatments are generally discussed within a skin-rejuvenation framework rather than as conventional volumizing filler.

Depending on the formulation used, treatment may be intended to support concerns involving skin quality, hydration, texture, and the appearance of fine lines.

This distinction matters.

A patient with delicate, crepey under-eye skin may have very different needs from someone whose primary issue is substantial volume loss.

The Under-Eye Area Requires Conservative Treatment

The tissue around the eye is anatomically sensitive.

There is relatively little room for error when choosing injectable treatments, which is why product selection, placement, treatment amount, anatomy, and patient candidacy deserve careful consideration.

More treatment does not automatically mean a better result.

A conservative, staged approach also gives the provider an opportunity to evaluate how the tissue responds before determining whether additional sessions are appropriate.

When Might You Start Seeing Results?

Early Changes May Be Subtle

Patients should not necessarily expect the under-eye area to look dramatically different immediately after the first treatment.

Depending on the treatment being performed, early changes may be subtle and related to the appearance of hydration or tissue quality.

The response can evolve over time.

This is one reason judging the final outcome too early can be misleading.

Rejuvenation and Immediate Correction Are Different Goals

Some aesthetic procedures create visible structural changes relatively quickly.

A tissue-quality treatment may work on a different timeline.

That means a patient shouldn’t necessarily compare the experience with dermal filler, where added volume can create an immediately apparent change in contour.

Understanding the intended mechanism and expected timeline before beginning treatment can prevent unnecessary disappointment.

Why a Series of Treatments May Be Recommended

Repeated Sessions Can Be Part of the Protocol

Some injectable rejuvenation approaches are performed as a series.

Rather than attempting to create a large change during one appointment, the provider may use staged treatments and evaluate progress between sessions.

This approach allows the treatment plan to respond to the patient rather than forcing every patient through an identical schedule.

If the tissue responds well, the provider can determine whether further treatment is worthwhile.

If another concern becomes more apparent, the strategy can also be reconsidered.

Midface Support Can Change the Under-Eye Treatment Plan

The Problem May Begin Below the Eye

The under-eye does not exist independently from the cheek and midface.

Changes in cheek volume and support can influence the transition between the lower eyelid and upper cheek, potentially making shadows or hollowness appear more pronounced.

Treating the under-eye directly without considering this relationship can lead to disappointing outcomes in some patients.

Aesthetic Nurse Marta discusses this concept further in its guide to why under-eye filler may fail when midface support is overlooked.

Whole-Face Assessment Can Prevent Overtreatment

Imagine a patient repeatedly treating the tear trough because it appears hollow.

If inadequate midface support contributes substantially to that appearance, continually adding treatment directly under the eye may not address the complete problem.

Evaluating facial proportions first can create a more conservative strategy.

Sometimes the best under-eye treatment plan includes treating the under-eye.

Sometimes it involves addressing surrounding structures.

Sometimes a combination is appropriate.

How Skin Quality Influences the Number of Treatments

Mild and More Advanced Concerns Are Different

A patient beginning treatment with relatively good skin quality and mild concerns may not require the same strategy as someone with more established changes.

Factors that can influence the starting point include:

Fine-line severity
Skin thickness
Crepiness
Hydration
Elasticity
Previous sun exposure
Previous aesthetic treatments
Age-related tissue changes

This doesn’t mean treatment numbers can be predicted simply from age.

Two people of the same age may have very different under-eye anatomy and skin characteristics.

Individual Response Matters

Even when two patients receive the same treatment protocol, their response may differ.

Biological variability is normal.

Providers therefore need to evaluate changes between appointments instead of promising that every patient will achieve a particular outcome after an exact number of sessions.

Before-and-after photographs taken under reasonably consistent conditions can help make those comparisons more useful.

What Happens During an Under-Eye Assessment?

The Provider Should Determine What Is Creating the Concern

An assessment should look beyond whether the under-eye appears dark.

Darkness may be influenced by several factors, including:

Shadowing
Hollowness
Pigmentation
Thin skin
Visible underlying vessels
Puffiness
Facial structure

Those causes don’t necessarily respond to the same treatment.

A treatment that improves skin quality may not eliminate a shadow caused predominantly by anatomy.

Previous Treatments Matter

Tell your provider about previous under-eye procedures.

This can include:

Dermal filler
PRP or PRF
Mesotherapy
Laser treatment
Microneedling
Surgery
Other injectable procedures

Knowing what has previously been placed or performed in the area can affect assessment and treatment planning.

This is particularly important if you experienced persistent swelling, irregularity, or dissatisfaction following previous treatment.

How Peptide Treatments Compare With Dermal Filler

They Solve Different Problems

Dermal filler is generally used when adding or restoring volume is an appropriate objective.

Peptide rejuvenation is not simply a lighter version of filler.

The treatment categories may target different concerns and should be selected according to anatomy and goals.

Someone with skin-quality concerns but little structural volume loss may not need the same approach as someone with pronounced hollowing.

Under-Eye Filler Is Not Automatically the Next Step

Patients sometimes assume that visible hollowness automatically means filler.

The under-eye is more complicated than that.

Existing puffiness, tissue characteristics, cheek support, anatomy, and previous filler can all influence whether direct tear-trough filler is appropriate.

A qualified assessment should determine candidacy rather than beginning with a predetermined product.

Where Mesotherapy May Fit Into Under-Eye Rejuvenation

Mesotherapy Is a Delivery Approach

Under-eye rejuvenation discussions sometimes include mesotherapy-based techniques.

Broadly, mesotherapy involves delivering selected substances into superficial tissue through multiple small injections, although the exact substances and techniques vary significantly.

Aesthetic Nurse Marta offers mesotherapy treatments as part of its broader injectable and rejuvenation services.

Because formulations vary, patients should ask exactly what product is being recommended, what it is intended to accomplish, and what evidence and experience support its use for their concern.

Product Matters as Much as Technique

“Peptide treatment” is a broad description.

Different formulations can contain different ingredients and may have different recommended protocols.

That is another reason a universal statement such as “everyone needs three treatments” is unreliable.

The specific product matters.

Ask your provider:

What exactly is being injected?
Why is it appropriate for my concern?
How many initial sessions are recommended?
How far apart are they?
When should results be evaluated?
What side effects should I expect?
Will maintenance potentially be needed?

Specific answers are more valuable than generic promises.

What Can Affect How Quickly You Notice a Difference?

Your Starting Point

Subtle concerns may require careful comparison to appreciate improvement.

More visible skin-quality changes may also require a longer or more comprehensive treatment plan.

Baseline photography can help.

Without it, people often forget precisely how an area looked before treatment, particularly when changes occur gradually.

Swelling Can Temporarily Affect Appearance

Injectable treatments around the eyes can produce temporary swelling, redness, tenderness, or bruising.

That can make early evaluation difficult.

Do not assume that the appearance immediately after treatment represents the final outcome.

Follow the aftercare instructions provided by your treating professional and allow the recommended evaluation period before deciding whether treatment has worked.

How Long Should You Wait Between Treatments?

Follow the Specific Product Protocol

Treatment intervals shouldn’t be invented from a generic online schedule.

Different formulations and techniques may have different recommended intervals.

Your provider should explain the proposed schedule before treatment begins.

That schedule should account for the specific product, treatment area, clinical assessment, and your response.

Give the Area Time to Settle

Rushing into another treatment before the area can be appropriately evaluated may make it harder to understand what is actually changing.

A staged approach allows swelling to resolve and the provider to evaluate the response.

At the follow-up, the discussion can then focus on whether the treatment is progressing as expected.

That creates a more informed decision about the next session.

Will Maintenance Treatments Be Needed?

Initial Treatment and Maintenance Are Different

An initial series is intended to establish improvement.

Maintenance is intended to support results later.

These should not automatically be treated as the same schedule.

If maintenance is recommended, frequency should reflect the treatment used and the individual’s response rather than an arbitrary calendar.

Your Needs Can Change Over Time

Facial ageing is dynamic.

Skin quality, volume distribution, and tissue support continue changing.

A treatment plan that made sense initially may therefore need adjustment later.

Periodic reassessment is preferable to automatically repeating the same procedure indefinitely.

How to Tell Whether Your Treatments Are Working

Look Beyond One Feature

Patients naturally focus closely on the under-eye after treatment.

However, improvement may be better evaluated through several factors:

Skin texture
Fine-line appearance
Overall tissue quality
Hydration appearance
Transition between the eye and cheek
How pronounced shadows appear
Overall rested appearance

Consistent photographs can be useful.

Compare images taken in similar lighting, angle, facial expression, and camera distance whenever possible.

Ask Whether the Result Matches the Original Goal

A treatment can create improvement without solving every under-eye concern.

Return to your original objective.

If the goal was improving skin quality and the skin appears healthier but structural hollowness remains, the treatment may have accomplished its intended purpose.

That remaining hollowness then deserves a separate discussion rather than automatically being interpreted as treatment failure.

Who May Not Be an Ideal Candidate?

Not Every Under-Eye Concern Is a Peptide Concern

A patient whose primary issue is significant structural volume loss, prominent fat pads, substantial skin laxity, or pigmentation may need another strategy.

Likewise, certain medical conditions, medications, pregnancy or breastfeeding status, allergies, active infections, or other individual factors may affect candidacy for elective injectable treatment.

A provider should obtain an appropriate history before proceeding.

Online information cannot determine individual suitability.

Expectations Matter

Someone expecting a dramatic surgical-level transformation from a minimally invasive treatment is unlikely to have appropriately aligned expectations.

Before treatment, understand what the procedure can realistically address.

Ask what it cannot address as well.

That question can be just as important.

Questions to Ask Before Starting Treatment

Make Sure the Plan Is Specific to You

Before committing to a series, consider asking:

What is causing my under-eye concern?
Why are peptides appropriate for me?
Which product will be used?
What improvement should I realistically expect?
How many sessions are initially recommended?
How will we decide whether I need another session?
What are the potential risks and side effects?
How long should I expect swelling or bruising?
Are there alternative treatments?
Is my midface contributing to the problem?
Will maintenance likely be recommended?
What happens if I don’t respond as expected?

A good consultation should make the treatment plan easier to understand—not more confusing.

Key Takeaways

So, How Many Under-Eye Peptide Treatments Are Needed?

There isn’t a universal answer to how many under-eye peptide treatments are needed because the appropriate plan depends on the patient, concern, product, protocol, anatomy, and response.

The most important points are:

Under-eye peptide rejuvenation may involve a treatment series.
The exact number should be individualized.
Product-specific protocols matter.
Early changes may be subtle.
Tissue-quality treatments shouldn’t be judged like immediate volumizing procedures.
Under-eye concerns can result from multiple causes.
Hollowness does not automatically mean the under-eye itself needs more treatment.
Midface support can influence under-eye appearance.
Skin quality and anatomy affect treatment planning.
Previous aesthetic treatments should be discussed during assessment.
Peptide treatments and dermal fillers have different purposes.
More sessions aren’t automatically better.
Swelling can temporarily interfere with evaluating results.
Treatment intervals should follow the provider’s recommended protocol.
Maintenance and initial treatment are separate considerations.
Consistent photographs can help track gradual changes.
A reassessment is appropriate when expected improvement isn’t occurring.

The most useful question is therefore not simply, “How many treatments will I need?” It is, “What is causing my under-eye concern, and what treatment plan makes the most sense for that specific cause?”

FAQs

How many under-eye peptide treatments are needed to see results?

There is no single treatment number that applies to every patient because protocols, products, concerns, anatomy, and individual responses vary. Some under-eye rejuvenation approaches are performed as a series, with progress evaluated between sessions rather than relying on one treatment. Your provider should recommend the number and spacing of treatments after assessing your under-eye area and explaining the specific product being used.

How quickly will I see results from under-eye peptide treatment?

Usually not immediately. Early changes after under-eye peptide treatment may be subtle, and some patients notice improvement during a treatment series while others need more time. The timeline depends on the formulation, your individual response and the type of improvement targeted. Temporary swelling can make the area hard to judge at first, so follow your provider's recommended evaluation timeline.

Can under-eye peptide treatments fix hollow under-eyes?

Peptide treatment alone may not correct under-eye hollows that are mainly structural. Peptide-based approaches focus on tissue quality rather than adding volume, so hollowness caused by volume loss or reduced midface support may need a different strategy. Shadowing, pigmentation and thin skin can also contribute to a hollow look, so a facial assessment should identify the cause first.

Are under-eye peptide treatments the same as filler?

No, peptide-based rejuvenation and dermal filler should not be considered interchangeable treatments. Fillers are generally used when adding or restoring volume is appropriate, while peptide-based approaches may be selected for different tissue-quality objectives depending on the formulation. The right option depends on anatomy, the underlying concern, previous treatments, and the result the patient hopes to achieve.

Do under-eye peptide results require maintenance?

Maintenance may be recommended depending on the specific treatment, initial response, ongoing facial changes, and the provider's protocol. The appropriate schedule should be determined through reassessment rather than assuming everyone needs treatment at the same interval. Your provider can evaluate whether additional treatment remains useful or whether another approach better addresses changes that develop over time.